A new study is open for people over 18 who have developed POTS after having a COVID infection. The clinical trial is to learn more about a new medication that may decrease POTS symptoms by decreasing autoantibodies.
To learn more about this study and to see if you qualify, visit:
Recommended Comments
There are no comments to display.
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.